Postmortem-derived iPSC models in substance use disorders research

Neuropsychopharmacology. 2024 Jan;49(1):349-350. doi: 10.1038/s41386-023-01703-3.

Authors

Emily Frances Mendez¹, Consuelo Walss-Bass²

Affiliations

¹ Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
² Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA. Consuelo.walssbass@uth.tmc.edu.

PMID: 37580459
PMCID: PMC10700533 (available on 2025-01-01)
DOI: 10.1038/s41386-023-01703-3

No abstract available

Publication types

News

MeSH terms

Autopsy
Cell Differentiation
Humans
Induced Pluripotent Stem Cells*
Neurons
Substance-Related Disorders*

Grants and funding

T32 GM129462/GM/NIGMS NIH HHS/United States